Prevalence and predictors of post-abortion modern contraceptive utilization among reproductive age women in Ethiopia.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
23 09 2023
23 09 2023
Historique:
received:
15
12
2022
accepted:
15
09
2023
medline:
25
9
2023
pubmed:
24
9
2023
entrez:
23
9
2023
Statut:
epublish
Résumé
The development of a post-abortion family plan is an integral part of comprehensive abortion care. In spite of this, it received insufficient attention as a means of breaking the cycle of repeated abortions, unintended pregnancies, and maternal deaths resulting from abortion. Therefore, this study examined post abortion modern contraceptive utilization among Ethiopian women as well as associated factors. The study was based on secondary data analysis of the Ethiopian Demographic and Health Survey 2016 data. A total weighted sample of 1236 reproductive age women was included. A multilevel mixed-effect binary logistic regression model was fitted to identify the significant associated factors of post abortion contraceptive use. Statistical significance was determined using Adjusted Odds Ratio (AOR) with 95% confidence interval. Overall prevalence of post abortion contraceptive use was observed to be 25.6% (95% CI: 23.24, 28.12). Women's age 15-24 (AOR = 2.34; 95% CI: 1.11, 4.93), and 25-34 (AOR = 1.94; 95% CI: 1.27, 2.98), married women (AOR = 2.6; 95% CI: 1.43, 4.96), women who had 1-4 (AOR = 4.13; 95% CI: 1.79, 9.57) and ≥ 5 number of children (AOR = 8.80; 95% CI: 3.30, 13.49), Being in metropolitan region (AOR = 9.14; 95% CI: 1.79, 12.48), women being in urban area (AOR = 1.85; 95% CI: 1.32, 2.24), and community media exposure (AOR = 1.75; 95% CI: 1.11, 3.56) were associated with post abortion modern contraceptive use. Post abortion modern contraceptive use in this study was low. Women age, current marital status, number of living children, residency, community media exposure, and region were significantly associated with post abortion modern contraceptive utilization. Therefore, it is better to provide ongoing health information about post-abortion family planning and its benefits, especially for people who live in rural and small peripheral regions, and public health policymakers should take both individual and community level factors into account when designing family planning programmes.
Identifiants
pubmed: 37741903
doi: 10.1038/s41598-023-42911-7
pii: 10.1038/s41598-023-42911-7
pmc: PMC10518002
doi:
Substances chimiques
Contraceptive Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
15932Informations de copyright
© 2023. Springer Nature Limited.
Références
Eur J Contracept Reprod Health Care. 2018 Feb;23(1):24-31
pubmed: 29436865
BMC Res Notes. 2018 Dec 27;11(1):928
pubmed: 30591074
Int J Environ Res Public Health. 2019 Mar 11;16(5):
pubmed: 30862098
Int J Reprod Med. 2019 Aug 19;2019:1327351
pubmed: 31531342
Afr J Reprod Health. 2017 Sep;21(3):89-95
pubmed: 29624932
Arch Public Health. 2021 Jun 4;79(1):93
pubmed: 34088347
Reprod Health. 2018 Jun 20;15(1):111
pubmed: 29925395
BMC Womens Health. 2019 Nov 14;19(1):138
pubmed: 31727045
Arch Public Health. 2019 Oct 30;77:46
pubmed: 31687139
Contracept Reprod Med. 2020 Dec 14;5(1):39
pubmed: 33317644
Glob Health Sci Pract. 2016 Sep 29;4(3):481-94
pubmed: 27571343
BMJ Open. 2019 Aug 28;9(8):e030485
pubmed: 31467055
Lancet Glob Health. 2020 Sep;8(9):e1152-e1161
pubmed: 32710833
Reprod Health. 2013 Jul 23;10:35
pubmed: 23875945
J Fam Plann Reprod Health Care. 2005 Jan;31(1):67-70
pubmed: 15720856
Syst Rev. 2021 Jun 9;10(1):172
pubmed: 34108044
Front Reprod Health. 2022 Jun 16;4:860514
pubmed: 36303617
Reprod Health Matters. 2017 Nov;25(51):48-57
pubmed: 29231790
Contracept Reprod Med. 2019 Nov 04;4:19
pubmed: 31700669
Med Sci (Basel). 2017 Dec 06;5(4):
pubmed: 29211008
BMC Pediatr. 2019 Jun 1;19(1):176
pubmed: 31153381
Contraception. 2013 Jan;87(1):17-25
pubmed: 22974595
BMJ Glob Health. 2020 Jul;5(7):
pubmed: 32690484
BMC Womens Health. 2020 Mar 26;20(1):61
pubmed: 32216823
Contraception. 2009 Jan;79(1):29-34
pubmed: 19041438
Arch Public Health. 2020 Oct 16;78:102
pubmed: 33088503
PLoS One. 2021 Jan 20;16(1):e0244808
pubmed: 33471864
BMC Public Health. 2020 May 24;20(1):775
pubmed: 32448212
J Biosoc Sci. 2021 Nov;53(6):908-923
pubmed: 33050954
Reprod Health. 2017 Aug 30;14(1):107
pubmed: 28854944
Kathmandu Univ Med J (KUMJ). 2011 Jul-Sep;9(35):179-84
pubmed: 22609503
Nagoya J Med Sci. 2015 Nov;77(4):551-61
pubmed: 26663934
Int J Environ Res Public Health. 2014 Sep 05;11(9):9256-72
pubmed: 25198687
BMC Public Health. 2015 Mar 18;15:262
pubmed: 25885372
Afr J Reprod Health. 2011 Sep;15(3):51-7
pubmed: 22574492
BMC Womens Health. 2015 Jul 17;15:52
pubmed: 26183090
BMC Womens Health. 2014 Mar 07;14(1):40
pubmed: 24602452
BMC Public Health. 2009 Jan 15;9:20
pubmed: 19146657
J Glob Health. 2021 Mar 01;11:03041
pubmed: 33763212
Int J Gynaecol Obstet. 2013 May;121(2):149-53
pubmed: 23499047
Int J Epidemiol. 2012 Dec;41(6):1602-13
pubmed: 23148108